Injection of autologous bone marrow cells into infarcted myocardium has been proposed to limit the deterioration of cardiac function following myocardial infarction (MI); unfortunately, the beneficial effects observed have been modest. One of the limiting factors is believed to be poor local survival of the injected cells, but the potential impact of apoptosis among the injected cells has yet to be assessed. Therefore, this study aimed to quantify the apoptosis rate in bone marrow mononuclear cells (BMMCs) prepared for cardiac therapy, and to analyze their effects in vitro on cardiomyoblast apoptosis and in vivo on cardiac function recovery following MI. Using rabbit BMMCs prepared by Ficoll gradient, apoptotic cells were detected via Annexin V (AnV) staining. The effects of depleting the apoptotic cell population by means of AnV magnetic beads was tested in vitro after coculture with cardiomyoblasts (H9c2 cells) and in vivo after cell injection into the infarcted area. Left ventricular ejection fraction and scar extent were assessed by echography and histology 2 months later. After Ficoll gradient isolation, 37.3% (33.4-37.9%) of BMMCs were found to be apoptotic (Apo Base BMMCs). AnV depletion decreased the proportion of apoptotic cells to 20% (17.6-32%) (Apo Low BMMCs). Rabbits treated in vivo with Apo Low BMMCs after MI presented with significantly improved left ventricular ejection fraction [41.4% (41.0-43.6%) vs. 34.6% (34.6-35.9%), p = 0.03), reduced scar extent [20.4% (17.9-24.3%) vs. 25.6% (17.9-27.9%), p = 0.057], and reduced rate of cardiomyocyte apoptosis compared to those treated with Apo Base BMMCs. H9c2 apoptosis was found to be higher after coculture with Apo Base than with Apo Low BMMCs [25.6% (22.6-29.6%) vs. 10.1% (6.6-12.6%), p = 0.03], a result partially reproduced by cocultures with microparticle-rich supernatants from BMMCs. The presence of apoptotic cells among BMMCs impairs the efficacy of cardiac cell therapy after MI, an effect possibly mediated by apoptotic microparticles.
INTRODUCTION
of this therapeutic approach (17, 25) . Indeed, the rate of early cell death among BMMCs is relatively high, probably due to the restricted supply of oxygen and nutrients, Heart failure following myocardial infarction (MI) remains a deadly and economically costly disease (2,22). local inflammation, and loss of microenvironment survival signals (5,10). In order to inject a sufficient Transplantation of autologous bone marrow mononuclear cells (BMMCs) has been proposed as a new method amount of viable cells into the patient, a battery of quality control tests must be performed on the BMMCs im-to limit the deterioration of cardiac function after MI. The first clinical trials involving cardiac cell therapy mediately prior to injection (6, 12, 18, 24) . Unfortunately, routine viability tests do not assess the presence of cells after MI have reported discordant and overall modest results (6, 12, 15, 18) . It is believed that poor local sur-that are still alive but engaged in an apoptotic process; thus, this aspect remains poorly documented. As apopto-vival of injected cells is a limiting factor to the efficacy tic cells could be exerting influence on numerous bio-BMMCs with FITC-labeled Annexin V (Miltenyi Biotec, Bergisch Gladbach, Germany) in order to detect the logical processes through release of microparticles to induce apoptosis in neighboring cells (9, 21, 23) , we redistribution of phosphatidylserine on the external cell membrane of apoptotic cells. Samples were analyzed on speculated that injection of apoptotic cells could impair the efficacy of cell therapy.
a Beckman Coulter flow cytometer (Beckman Coulter; Villepinte, France), and results analyzed by accompany-In this study, we first aimed to document the presence of apoptotic cells among BMMCs that had been ing Expo32 software. Apoptotic BMMCs were defined as Annexin V positive − PI negative, dead cells as routinely prepared for use in cardiac cell therapy. Then, in order to assess the role of apoptotic cells in this set-Annexin V positive − PI positive, and viable nonapoptotic cells as Annexin V negative − PI negative. ting, we compared the effects of BMMCs, partially depleted from apoptotic cells (Apo Low ) or not (Apo Base ), on
The proportion of apoptotic BMMCs was also assessed by detecting the presence of DNA lesions by us-H9c2 survival in vitro, and in vivo using a rabbit model of MI.
ing cytoimmunochemistry (Apostain technique; Bender MedSystems, Vienna, Austria). The Apostain technique MATERIALS AND METHODS is based on the characteristic of increased sensitivity of Animals apoptotic cells' DNA to thermic denaturation. Briefly, BMMCs were spun down onto histological slides, and All experiments were conducted in syngeneic New permeabilized with saponine. The DNA denaturation ca-Zealand rabbits weighing 3.5-4.5 kg. Rabbits were pacity was determined by heating cells at 56°C in the housed in individual cages under standard conditions of presence of formamide. Slides were cooled down for 5 temperature (14-20°C) and light (12 h per day) with min in cold PBS. Nonspecific blocking was performed food and water provided ad libitum. A delay of 1 week by incubation in 3% fat milk for 20 min at 37°C. Slides between each animal's arrival and the initiation of exwere incubated with monoclonal antibody (MAb) F7-26, periments was systematically respected. All experiments specific to single-stranded DNA, for 30 min at room were conducted in accordance with the European Comtemperature. MAb F7-26 antigen detection was permunities Council directive (86/609/EEC) after approval formed by using mouse anti-IgM FITC-labeled antibody was obtained from the local Ethics Review Board of for 30 min at room temperature. Finally, slides were Lille University, and conformed to the US National Incounterstained with DAPI and the proportion of apoptostitutes of Health guidelines for the care and use of labotic cells was determined as the ratio of green FITC-posiratory animals.
tive cells to DAPI-positive cells.
BMMC Isolation and Assessment of Cell Viability
Assessment of Apoptosis Pathway Activation Bone marrow (BM) was isolated from the rabbit's To evaluate the activation of apoptotic pathways in posterior leg bone. Bone extremities were surgically BMMCs, we analyzed the activation of mitochondrial opened under sterile conditions and bones flushed with and Fas ligand receptor pathways. We analyzed the mianticoagulant solution (ACD-A; Maco Pharma, Moutochondrial pathway through evaluation of mitochonvaux, France) to isolate the crude BM, which was then drial membrane potential by flow cytometry. In apoptofiltered through a 100-µm filter and centrifuged to pellet tic cells, the decrease of mitochondrial membrane potential (400 × g, 10 min at room temperature). Mononuclear results in the loss of mitochondrial capacity to accumucells were isolated by the Ficoll gradient technique. late lipophilic and cationic probes like JC1 (5,5′,6,6′-Briefly, BM cells were resuspended in IMDM modified tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanin medium (Dulbecco's medium modified by Iscove with iodide; Sigma-Aldrich, St. Louis, MO, USA). As a con-GlutaMAX I and 0.25 mM HEPES; Invitrogen, Carlssequence, monomers of JC1 remain in the cytosol and bad, CA, USA) and placed on 1.07 density lymphocytes emit green fluorescence (527 nm). In nonapoptotic cells separation solution (Eurobio, Les Ulis, France), folaggregates of JC1 accumulate in the mitochondria, due lowed by centrifugation (450 × g, 30 min at room temto the high membrane potential, and emit red fluoresperature). BMMCs were isolated and resuspended in cence (590 nm). The ratio of red to green fluorescence IMDM. For in vivo experiments and intramyocardial inis dependent only on mitochondrial membrane potential. jections, 2 × 10 6 BMMCs were diluted in 100 µl. Imme-We used FCCP (mesoxalonitrile-4-trifluoromethoxyphediately after Ficoll gradient isolation, cell viability was nylhydrazone; Sigma-Aldrich) as a positive control. assessed by flow cytometry with the use of propidium FCCP artificially depolarizes the mitochondrial memiodide (PI).
brane, which in turn simulates the decrease of the mito-Assessment of Cell Apoptosis chondrial membrane potential as observed in apoptotic cells. Each analysis was carried out with samples of 0.5 × Simultaneous to the evaluation of cell viability, assessment of apoptosis was performed by incubation of 10 6 BMMCs.
To analyze the Fas ligand receptor pathway, we used same protocol and the chest was reopened. Scar tissue was identified as pale akinetic tissue. Using a 29-gauge a reverse-transcriptase polymerase chain reaction (RT-PCR) technique. Briefly, samples of 5 × 106 cells were needle, placebo (buffer PBS) or 2 × 10 6 freshly isolated syngeneic BMMCs (either Apo Base or Apo Low ) were in-incubated with a primer designed from the messenger Ribosomal Nucleic Acid (mRNA) of Oryctolagus cuni-jected into two spots, at 1 × 10 6 BMMCs each, in the border zone of the MI scar. Success of the injection was culus (European rabbit) AB021296 for the antigen Fas of 2003 bp (Eurogentec France SASU). BMMCs controlled by the formation of a little epicardial wheal. The needle was cautiously removed in order to limit treated with endotoxin were used as positive controls of apoptotic cells. The expression level of glucose-3-leakage of the cell suspension. phosphodeshydrogenase (G3PDH) was assessed for use Assessment of BMMC Survival and of Cardiomyocyte as a standard control of the RT-PCR technique.
Apoptosis Following Intramyocardial Injection Preparation of Apo Low BMMCs and Assessment
In order to determine the impact of apoptotic of Cell Function BMMCs on cell survival after intramyocardial injection, intramyocardial injection of 2 × 10 6 Apo Base BMMCs or Immediately after Ficoll gradient isolation, a portion of BMMCs was incubated with Annexin V-labeled mi-Apo Low BMMCs was performed 1 week after MI. Immediately after Ficoll gradient isolation, cells were labeled crobeads (Annexin V Microbeads Kit; Miltenyi Biotec, Bergisch Gladbach, Germany). Cells were then sorted in with Hoechst 33342 (Molecular Probes, Invitrogen, Carlsbad, CA, USA) and then injected. Animals were MS type columns through a magnetic separator (MIDI-MACS; Miltenyi Biotec, Bergisch Gladbach, Germany) sacrificed at 1, 2, and 24 h after cell injection to perform histological analysis (n = 5 animals per time point in that retained Annexin V-positive cells. The residual cell suspension was depleted of apoptotic BMMCs and des-each group). To assess BMMCs survival rate, we developed a specific method of Hoechst-labeled nuclei detec-ignated as Apo Low BMMCs. In contrast, BMMCs that did not undergo the depletion procedure were designated tion based on fluorescent microscopy. After heart excision (at 1, 2, and 24 h following BMMC injection, n = 5 as Apo Base BMMCs. We compared the capacity of Apo Low and Apo Base BMMCs for colony-forming unit (CFU) and animals per time point in each group), the BMMC injection spot (IS) was localized as a high Hoechst-labeled migration capacity. To assess CFU capacity, 10 4 cells were plated in METHOCULT media (GF H4435; Stem-nuclei density area within the border zone of myocardial infarction. Twelve fields were acquired by a CCD cam-Cell Technologies Inc., Vancouver, BC, Canada) for 14 days. Colonies were then counted by two independent era and fluorescent microscope around the injection spot. Cell count was automatically performed by Meta-investigators. The experiments were performed in triplicate and results expressed as number of colonies/cell morph Imaging system software ( Fig. 1 ). Apoptosis in myocardial host tissue was assessed by culture plates (CFU-GM; colonies = 50 cells). In order to assess migration capacity of BMMCs, 250 µl of cell Apostain on frozen cardiac tissue sections sampled 24 h and 2 months after injection of BMMCs. suspension (4 × 10 5 cells/ml) were plated in Boyden chambers with either 500 µl of standard medium, or Assessment of Left Ventricular Remodeling standard medium + SDF-1 (100 ng/ml) or standard meand Left Ventricular Ejection Fraction dium + VEGF (50 ng/ml) for 24 h at 37°C. The supernatant was then discarded, the chambers fixed with 4% Five rabbits were included in each group: placebo, Apo Base BMMCs, and Apo Low BMMCs. In vivo measure-PFA for 10 min, and then colored with Giemsa to obtain cell count. Transmigrated cells were counted by two in-ments of left ventricular (LV) dimensions and systolic function were performed under anesthesia by transtho-dependent investigators. Results are expressed as the ratio between the number of cells that migrated in the racic echocardiography with a sequoia Acuson 512 and a 15 MHz linear pediatric probe. LV dimensions and presence or in the absence of cytokine.
systolic function were assessed before MI, 1 week after Model of MI and Intramyocardial Injection of BMMCs MI, just before the BMMC injection, and 2 months after cell therapy and just before sacrifice. In order to Rabbits were anesthetized with ketamine (50 mg/kg) and xylazine (6 mg/kg) and then intubated for mechani-evaluate LV remodeling, we measured LV end diastolic and end systolic diameters (LVEDD and LVESD, re-cal ventilation (SAR-830A Ventilator, Harvard Apparatus, MA, USA). Myocardial infarction was performed spectively) and estimated the corresponding volumes (LVEDV and LVESV) with the following simplified by transient ligation of the main left descendant coronary artery for 1 h, followed by reperfusion. Coronary
Simpson's formula: (0.85 × short axis area × long axis area)/long axis diameter. Left ventricular ejection frac-ligation was confirmed by myocardium pallor and kinetic alteration. BMMCs injection was performed 1 tion (LVEF) was estimated by the Simplified Simpson method (LVEF = LVEDV − LVESV/LVESV). week after MI. Animals were anesthetized using the 
Assessment of Cardiac Scar After MI
oxygen for 24 h) in order to mimic the condition of the myocardial border zone after MI. To evaluate the level Two months after MI and cardiac cell therapy, rabbits of oxidative stress, H9c2 cells were exposed for 30 min were sacrificed; hearts were then excised, and placed in to H2DCF (2′,7′-dichlorodihydrofluorescein diacetate; OCT solution before freezing in isopentane and liquid Molecular Probes, Invitrogen), a nonfluorescent dye that nitrogen. LV cross sections, 7 µm in thickness, were is converted into fluorescent DCF in the presence of hyobtained as oriented along the LV short axis. A Masdrogen peroxide and peroxynitrite. The level of oxidason's trichrome staining was performed to delineate the tive stress was then evaluated by fluorescence microsextent of the fibrotic infarct region. Using Sigma Scancopy. We assessed the impact of apoptotic BMMCs on Pro software, the extent of both endocardial and epicarsurrounding H9c2 in different culture conditions: H9c2 + dial scar formation was measured. For each tissue seccontrol media; H9c2 + 2 × 10 6 Apo Base BMMCs; H9c2 + tion, endocardial scar was calculated as extent of 2 × 10 6 Apo Low BMMCs; H9c2 + supernatant from Apo Base endocardial fibrosis over total endocardial circumfer-BMMCs; and H9c2 + supernatant from Apo Low BMMCs. ence. Similar calculation was performed for the epicar-After 24 h, nonadherent cells (i.e., BMMCs) were redial side. MI size was reported as the average of the moved and adherent cells were trypsinized and morphoextent of the endo-and epicardial scars over three seclogical analysis was performed on cytospins to confirm tion levels (apex, midventricular, and basal).
that apoptotic cells were H9c2. The rate of H9c2 apopto-In Vitro Assays: Impact of Apoptotic BMMCs and of sis was assessed by Apostain technique.
Apoptotic Microparticles on Cardiomyoblast Apoptosis
Microparticles were isolated from Apo Base and Apo Low BMMC supernatants by double centrifugation, as pre-H9c2 cells (European Collection of Cell Cultures) were plated in modified DMEM (DMEM + 10% FCS + viously described for platelets (7) . Microparticles were analyzed and quantified by flow cytometry after identifi-1% penicillin-streptomycin) in hypoxic condition (1% cation of their size (0.5-0.8 µm) using fluorescent beads was reduced from 37.3% (33.4-37.9%) (Apo Base group) to 20.0% (17.6-32.0%) (Apo Low group) as assessed by of different sizes for gating (MEGAMIX; Biocytex, Marseille, France) and Annexin V expression. flow cytometry (p = 0.001), and from 33.9% (27.3-39.5%) to 17.3% (12.5-24.4%) as assessed by immuno-Statistical Analysis cytochemistry (p < 0.0001) (Fig. 3A) . To further explore the status of apoptotic BMMCs, we analyzed the activa-Results were expressed as median (25th and 75th percentiles). Comparison of continuous variables between tion of apoptosis pathways. We observed a significantly higher activation of the mitochondrial pathway among more than two groups was performed using the Kruskall-Wallis test. In cases of significant values of p < 0.05, Apo Base BMMCs compared to Apo Low BMMCs (Fig. 3B) . Indeed, the cell rates with low mitochondrial membrane the Mann-Whitney or Wilcoxon test were performed to determine the differences between groups, after Bonfer-potential were, respectively, 27.3% (25.2-32.2%) and 14.3% (12.1-23.4%) (p = 0.004). The expression of roni correction when necessary. Values were considered significant if p < 0.05. Analyses were performed with FAS receptor ligand, assessed by PCR, was also higher in Apo Base compared to Apo Low BMMCs (Fig. 3C ). SPSS software (release 13.0; SPSS Inc., Chicago, IL, USA).
Depletion of Apoptotic Cells From BMMCs Does Not RESULTS

Modify BMMC Functions Evidence for the Presence of Apoptotic BMMCs After
The number of CFU-GM colonies was not different BM Isolation between Apo Low BMMCs and Apo Base BMMCs [138 (49-312) and 129.5 (59-219), respectively, p = 0.72].
After isolation of BMMCs by Ficoll gradient, cell vi-
There was no difference in the migration capacity beability was determined to be 91.7% (86.1-95.4%) as astween Apo Low BMMCs and Apo Base in response to SDF sessed by flow cytometry and IP staining. After gating [1.9 (1.4-1.9) and 1.7 (1.1-2.0) for Apo Low and Apo Base the viable BMMCs, we observed an average of 37.3% BMMCs, respectively, p = 0.82) or to VEGF [1.3 (1.1-(33.4-37.9%) apoptotic cells as assessed by Annexin V 1.6) and 1.3 (1-1.3) for Apo Low and Apo Base BMMCs, staining ( Fig. 2A) , and 33.85% (27.31-39.47%) as asrespectively, p = 0.83]. sessed by immunocytochemistry ( Fig. 2B ).
Assessment of BMMC Survival and of Cardiomyocyte Efficacy of Apoptotic BMMC Depletion Apoptosis Following Intramyocardial Injection and Assessment of Apoptosis Pathway Activation
After depletion of apoptotic cells with the use of Animals received unselected (Apo Base ) BMMCs or selected (Apo Low ) BMMCs 1 week after MI, and were sac-Annexin V microbeads, the proportion of apoptotic BMMCs Representative aspect of mitochondrial membrane potential assessment with the use of cationic probe JC1. In nonapoptotic cells, JC1 aggregates in the mitochondria emit predominantly red fluorescence (i.e., high red/green ratio). In apoptotic cells, the decrease of mitochondrial potential membrane results in the release of JC1 monomers in the cytoplasm that emit predominantly green fluorescence (i.e., low red/green ratio). In this example, the proportion of BMMCs with low mitochondrial potential membrane was 25% in Apo Base and 8% in Apo Low BMMCs. (C) Expression of FAS receptor pathway was assessed by polymerase chain reaction technique. Fas receptors were overexpressed in Apo Base BMMCs. BMMCs: bone marrow mononuclear cells; GAPDH: glyceraldehyde-3-phosphate dehydrogenase. rificed for histological analysis at 1, 2, and 24 h follow-tic cells could be identified, with no significant difference between of Apo Base BMMCs and Apo Low BMMCs. ing cell injection. The number of residual BMMCs detected at 1 and 2 h after injection was similar in the Depletion of Apoptotic BMMCs Limits LV Remodeling, two groups (Fig. 4A ). Twenty-four hours after injection, Improves LVEF, and Reduces Scar Extent After MI the number of BMMCs detected in animals who had received Apo Low BMMCs was twice as high as that in
The effects of Apo Base , Apo Low BMMCs, and placebo (buffer PBS) injection on cardiac function were assessed animals who had received Apo Base BMMCs [8,383 (6,649-10,470) vs. 4,264 (4,053-5,555), respectively, in vivo using the same rabbit model of MI. At baseline before MI, and 1 week after MI, we observed no differp = 0.05]. After standardization to the initial number of injected nonapoptotic BMMCs, the ratio of remaining ences in echocardiographic parameters between the three groups. After 2 months, LVEF had significantly viable cells to injected viable cells remained higher in the Apo Low group than in the Apo Base group. Furthermore, improved in animals treated with Apo Low BMMCs [41.4% (41.0-43.6%)] versus control [32.7% (32.7-33.1%), p = Apostain analysis of cardiac tissue sections showed more apoptotic cells in the border zone of the Apo Base 0.034], but not in the Apo Base group [34.6% (34.6-35.9%), p = 0.2 vs. control] (Fig. 5A) . A similar differ-group [n = 28 cells (22-29)] than of the Apo Low group [n = 11 cells (2-12), p = 0.045] (Fig. 4B ). Two months ence was observed in the limitation of LV dilation, which was significantly reduced only in those animals after MI, after careful examination of tissue sections by morphological analysis, we saw no BMMC in the infarct treated with Apo Low BMMCs (Fig. 5B ). Injection of Apo Base BMMCs tended to reduce the scar surface area and in the border zone. Moreover, only very few apopto-compared to injection of placebo [Apo Base = 25.6% (17.9-18.7%) vs. 25 .6% (22.6-29.6%), p = 0.03]. By contrast, supernatants of Apo Low BMMCs did not induce a signifi-27.9%) vs. control = 31.2% (30.2-46.2%), p = ns]. Injection of Apo Low BMMCs further reduced scar surface cant increase of apoptosis [8.6% (5.4-12.5%) vs. 7.6% (6.6-11.3%), p = 0.31]. Interestingly, supernatants of [20.4% (17.9-24.3%), p = 0.057 vs. control]. Representative aspects of the scar in each of the three groups, 2 Apo Low BMMCs induced a significantly lower rate of apoptosis than was induced by Apo Base BMMCs superna-months after MI, are shown in Figure 5C . tants [16.7% (15.3-18.7%) vs. 8.6% (5.4-12.5%), p = Apoptotic BMMCs Increase Apoptosis 0.03]. The supernatant from Apo Base BMMCs contained of Cardiomyoblasts significantly more microparticles than the supernatant from Apo Low BMMCs [2,558 MP/µl (1,740-12,612) vs. In a single culture model of H9c2, the level of oxidative stress after 24 h of hypoxia was significantly higher 1,064 MP/µl (213-2,014), respectively, p = 0.03]. than after culture in normoxia conditions [885 AU DISCUSSION (870-902) vs. 468 AU (452-482), p = 0.028], as was the proportion of apoptotic cells [7.4% (6.4-7.6%) vs.
In this study, we demonstrate that up to 30% of BMMCs, prepared for cardiac cell therapy, are engaged 1.3% (0.5-2.0%), respectively, p = 0.03]. In a coculture model with BMMCs, the proportion of apoptotic H9c2 in the apoptotic process. Partial elimination of these apoptotic BMMCs from the cell therapy product prior to cardiomyoblasts significantly increased in the presence of Apo Base BMMCs [25.6% (22.6-29.6%) vs. 7.6% (6.6-injection into infarcted myocardium 1) increased in vivo survival of injected BMMCs, 2) decreased cardiomyo-11.3%) in control group, p = 0.003], but not in the presence of Apo Low BMMCs [10.2% (6.6-12.6%) vs. 7.6% cyte apoptosis in the border zone, and 3) improved the efficacy of cell therapy on cardiac function. Moreover, (6.6-11.3%), p = 0.24) (Fig. 6 ). Culture of H9c2 with supernatants of Apo Base BMMCs induced a significant coculture of BMMCs with cardiomyoblasts induced cardiomyoblast apoptosis when BMMCs or their super-increase in apoptosis [16.7% (15.3-18.7%) vs. 7.6% (6.6-11.3%), p = 0.03], but this effect was lower than natants were used. This effect was blunted after depletion of apoptotic BMMCs was carried out before cocul-that obtained with Apo Base BMMCs [16.7% (15.3- ture. Taken together, these results demonstrate that condensation (Apostain technique) explored the last step (20) . We observed a similar proportion of apoptotic apoptotic BMMCs, which are commonly present among the cell therapy product, act to minimize the benefit of BMMCs with these three techniques. These results are in line with the notion that apoptosis is a natural regula-cardiac cell therapy. Our results suggest that it could be at least partially related to an increase in cardiomyocyte tory process of hematopoiesis that might be further increased by sampling and isolation procedures (8) . The apoptosis, through both direct and paracrine mechanisms.
proportion of apoptotic BMMCs before injection had not yet been explored in experimental or clinical studies (ei-A Significant Proportion of Apoptotic BMMCs ther cardiac or hematological). In our study, the propor-Is Observed After Density Gradient Isolation tion of apoptotic cells was assessed immediately after bone marrow isolation. The time between bone marrow The first observation in this study was a significant proportion of BMMCs being apoptotic before their in-harvest and BMMCs isolation will certainly be longer in clinical settings and the use of autologous serum might jection into the myocardium. Since apoptosis is a dynamic process that is difficult to assess, we performed limit the number of apoptotic cells, although it remains to be demonstrated. Temperature variation should be three complementary techniques to explore three different steps of the process. The decrease of mitochondrial avoided and cells kept at room temperature during all the process of BMMCs preparation. potential membrane was used to represent an early step, whereas translocation of phosphatidylserine (Annexin V In order to evaluate the role of apoptotic cells in the setting of cardiac cell therapy, we chose to deplete labeling) explored an intermediate step, and chromatin BMMCs in apoptotic cells by immunoadsorption on compared to nondepleted ones. Together, these results suggest that decreasing the number of injected apoptotic Annexin V-coated beads. This method is based on Annexin V binding to phosphatidylserine translocated to cells not only increased local survival of injected cells but also limited cardiomyocyte apoptosis. Other groups the external side of the cell membrane. This method of magnetic cell sorting led to a significant decrease of have previously reported that the transplantation of mesenchymal stem cells modified to resist apoptosis im-Annexin V-positive cells from the overall BMMC population, although the depletion was only partial. This proved the efficacy of cell therapy. Hence, mesenchymal stem cells genetically modified to overexpress antiapo-method has the advantage of producing clinical grade cells while preserving proliferative and migration func-ptotic protein such as akt (14) and bcl-2 (11) limited scar extension and improved cardiac function recovery. tions (3).
However, the use of genetically engineered cells is not Depletion of Apoptotic Cells Increases BMMC ready for clinical application.
Survival and Decreases Cardiomyocyte Apoptosis in Infarcted Myocardium
Impact of Apoptotic BMMCs on Surrounding Cardiomyoblasts Twenty-four hours after injection, the number of injected BMMCs detected in the myocardium was higher In order to investigate the possible link between apoptosis of BMMCs and that of cardiomyocytes, we ana-in animals who had received depleted, rather than nondepleted, cells. Obviously, this effect may be the direct lyzed the effect of Apo Base BMMCs and Apo Low BMMCs after in vitro coculture with H9c2. The rate of apoptotic result of cell death occurring in injected apoptotic cells. However, this effect remained significant after normal-H9c2 was significantly higher when H9c2 were cocultured with Apo Base BMMCs than with Apo Low BMMCs. ization to the initial number of injected nonapoptotic cells. This suggests that the limitation of the number of Interestingly, the deleterious effect of Apo Base BMMCs was partially reproduced when H9c2 were cultured in apoptotic cells improved the overall survival of injected cells.
the presence of supernatant from Apo Base BMMCs, but not in the presence of supernatant from Apo Low BMMCs. Simultaneously, Apostain analysis showed a lower rate of apoptotic cardiomyocytes in the border zone after This finding demonstrates that H9c2 apoptosis is at least partially induced by paracrine mechanisms, which could injection of those BMMCs depleted in apoptotic cells, Figure 6 . Apoptotic BMMCs increase apoptosis of surrounding H9c2 cardiomyoblasts. Coculture of H9c2 with Apo Base BMMCs increased the rate of apoptotic H9c2. This was not observed when H9c2 were cocultured with Apo Low BMMCs. Incubation of H9c2 with the supernatant of Apo Base BMMCs partially reproduced this effect. *p = 0.003 versus H9c2 and versus Apo Low BMMCs. #p = 0.03 versus H9c2 Apo Low BMMC supernatant. §p = 0.03 versus H9c2 and versus H9c2 + Apo Low BMMC supernatant. be mediated by microparticles or by microparticle-Conclusions derived factors.
BMMCs prepared for cardiac cell therapy were found to contain a significant proportion of apoptotic cells, Limitation of Apoptotic BMMCs Improves the Efficacy which impaired the efficacy of cell therapy through diof Cell Therapy After MI rect and indirect mechanisms. The depletion of apoptotic In the rabbit model, we assessed the effects of BMMCs prior to injection improved the efficacy of cell BMMCs on LV remodeling and systolic function recovtherapy after acute MI. Our results suggested that imery after MI. Cell therapy based on Apo Base BMMCs provement of cell quality through limitation of apoptotic ended up in the improvement of LV remodeling and syscells prior to injection has the potential to improve cartolic function. Of note, the depletion of apoptotic diac function recovery after cell therapy. BMMCs significantly enhanced the magnitude of LVEF
